Doxil, Bevacizumab and Temsirolimus Trial

NCT00761644 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Advanced Cancer

Interventions

DRUG: Doxil
DRUG: Bevacizumab
DRUG: Temsirolimus

Sponsor

M.D. Anderson Cancer Center